DIFFERENTIAL CONSEQUENCES OF RENAL-FAILURE ON THE PHARMACOKINETICS OF OXPRENOLOL AND ITS MAIN METABOLITE

被引：11

作者：

DAYER, P

GLASSON, P

BALANT, L

STRIBERNI, R

FABRE, J

机构：

来源：

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 1983年 / 8卷 / 02期

关键词：

D O I：

10.1007/BF03188744

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：181 / 188

页数：8

共 18 条

[1]

BALANT L, 1980, Nephrologie, V1, P177

[2] INFLUENCE OF RENAL-FAILURE ON THE HEPATIC-CLEARANCE OF BUFURALOL IN MAN [J].

BALANT, L ;

FRANCIS, RJ ;

TOZER, TN ;

MARMY, A ;

TSCHOPP, JM ;

FABRE, J .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :421-438

[3]

BALANT L, 1977, KIDNEY INT, V12, P72

[4]

BALANT LP, 1980, CONCEPTS DRUG META A, P311

[5]

BIANCHETTI G, 1976, Clinical Pharmacokinetics, V1, P373, DOI 10.2165/00003088-197601050-00004

[6] RELATION BETWEEN PLASMA CONCENTRATIONS AND CARDIOVASCULAR EFFECTS OF ORAL OXPRENOLOL IN MAN [J].

BRUNNER, L ;

IMHOF, P ;

JACK, D .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) :3-9

[7]

DAYER P, 1981, SCHWEIZ MED WSCHR, V111, P1915

[8] SIMPLIFIED METHOD FOR DETERMINATION OF OXPRENOLOL AND OTHER BETA-RECEPTOR BLOCKING-AGENTS IN BIOLOGICAL-FLUIDS BY GAS-LIQUID-CHROMATOGRAPHY [J].

DEGEN, PH ;

RIESS, W .

JOURNAL OF CHROMATOGRAPHY, 1976, 121 (01) :72-75

[9]

GUGLER R, 1979, ADV PHARM THER, V6, P67

[10]

MASON WD, 1976, CLIN PHARMACOL THER, V20, P401

← 1 2 →